Advisor Group Holdings, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

$52.6 Billion
Q2 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 11,873 shares of ARWR stock, worth $449,393. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,873

Previous 36,764 67.7%

Holding current value

$449,393

Previous $580,000 67.76%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Sep 04, 2025	SELL	$9.99 - $16.97 $248,661 - $422,400	-24,891 Reduced 67.7%	11,873 $187,000
Q2 2025 Aug 13, 2025	BUY	$9.99 - $16.97 $19,470 - $33,074	1,949 Added 5.6%	36,764 $580,000
Q1 2025 May 12, 2025	BUY	$12.74 - $21.53 $350,350 - $592,075	27,500 Added 375.94%	34,815 $443,000
Q4 2024 Jun 06, 2025	BUY	$17.7 - $26.34 $40,975 - $60,977	2,315 Added 6.65%	37,130 $698,000
Q4 2024 Feb 07, 2025	SELL	$17.7 - $26.34 $530,433 - $789,357	-29,968 Reduced 80.38%	7,315 $137,000
Q3 2024 Nov 13, 2024	SELL	$19.36 - $29.54 $28,072 - $42,833	-1,450 Reduced 3.74%	37,283 $721,000
Q2 2024 Aug 13, 2024	SELL	$21.87 - $28.24 $6,254 - $8,076	-286 Reduced 0.73%	38,733 $1.01 Million
Q1 2024 May 10, 2024	SELL	$27.21 - $39.48 $18,040 - $26,175	-663 Reduced 1.67%	39,019 $1.12 Million
Q4 2023 Feb 12, 2024	SELL	$21.2 - $31.03 $173,882 - $254,508	-8,202 Reduced 17.13%	39,682 $1.21 Million
Q3 2023 Nov 13, 2023	BUY	$26.2 - $36.08 $186,020 - $256,168	7,100 Added 17.41%	47,884 $1.29 Million
Q2 2023 Aug 10, 2023	SELL	$25.16 - $41.38 $8,378 - $13,779	-333 Reduced 0.81%	40,784 $1.45 Million
Q1 2023 May 12, 2023	SELL	$23.68 - $38.51 $38,006 - $61,808	-1,605 Reduced 3.76%	41,117 $1.04 Million
Q4 2022 Feb 10, 2023	BUY	$28.0 - $40.56 $906,696 - $1.31 Million	32,382 Added 313.17%	42,722 $1.73 Million
Q3 2022 Nov 14, 2022	SELL	$29.63 - $48.31 $2,725 - $4,444	-92 Reduced 0.88%	10,340 $342,000
Q2 2022 Aug 10, 2022	SELL	$27.79 - $50.61 $9,976 - $18,168	-359 Reduced 3.33%	10,432 $368,000
Q1 2022 May 04, 2022	SELL	$39.62 - $69.97 $546,082 - $964,396	-13,783 Reduced 56.09%	10,791 $1.54 Million
Q3 2021 Nov 05, 2021	SELL	$58.38 - $84.96 $495,879 - $721,650	-8,494 Reduced 25.69%	24,574 $1.53 Million
Q2 2021 Aug 02, 2021	BUY	$62.15 - $90.32 $976,811 - $1.42 Million	15,717 Added 90.58%	33,068 $2.74 Million
Q1 2021 May 13, 2021	BUY	$61.35 - $90.47 $299,142 - $441,131	4,876 Added 39.09%	17,351 $1.15 Million
Q4 2020 Feb 10, 2021	SELL	$43.82 - $85.37 $392,977 - $765,598	-8,968 Reduced 41.82%	12,475 $958,000
Q3 2020 Nov 12, 2020	BUY	$33.21 - $51.27 $50,744 - $78,340	1,528 Added 7.67%	21,443 $923,000
Q2 2020 Aug 14, 2020	BUY	$26.12 - $43.27 $170,354 - $282,206	6,522 Added 48.7%	19,915 $860,000
Q1 2020 May 18, 2020	BUY	$20.56 - $63.12 $275,360 - $845,366	13,393 New	13,393 $385,000

Others Institutions Holding ARWR

# of Institutions

332

Shares Held

99.7M

Call Options Held

444K

Put Options Held

568K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $4.01B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History